Report Summary
Alendronate is in a class of drugs called bisphosphonates used to prevent and treat certain types of bone loss (osteoporosis) in adults.
The global Alendronate market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Alendronate market based on company, product type, end user and key regions.
This report studies the global market size of Alendronate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alendronate in these regions.
This research report categorizes the global Alendronate market by top players/brands, region, type and end user. This report also studies the global Alendronate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Teva
Mylan
Apotex
Pfizer
Novartis
Eli Lilly
Amgen
Tecoland
Taj Pharmaceuticals
Market size by Product
5 mg Tablets
10 mg Tablets
35 mg Tablets
70 mg Tablets
Market size by End User
Postmenopausal Osteoporosis
Men with Osteoporosis
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Alendronate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Alendronate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alendronate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alendronate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Alendronate are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alendronate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Alendronate Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Alendronate Market Size Growth Rate by Product
1.4.2 5 mg Tablets
1.4.3 10 mg Tablets
1.4.4 35 mg Tablets
1.4.5 70 mg Tablets
1.5 Market by End User
1.5.1 Global Alendronate Market Size Growth Rate by End User
1.5.2 Postmenopausal Osteoporosis
1.5.3 Men with Osteoporosis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alendronate Market Size
2.1.1 Global Alendronate Revenue 2017-2027
2.1.2 Global Alendronate Sales 2017-2027
2.2 Alendronate Growth Rate by Regions
2.2.1 Global Alendronate Sales by Regions
2.2.2 Global Alendronate Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Alendronate Sales by Manufacturers
3.1.1 Alendronate Sales by Manufacturers
3.1.2 Alendronate Sales Market Share by Manufacturers
3.1.3 Global Alendronate Market Concentration Ratio (CR5 and HHI)
3.2 Alendronate Revenue by Manufacturers
3.2.1 Alendronate Revenue by Manufacturers (2017-2020)
3.2.2 Alendronate Revenue Share by Manufacturers (2017-2020)
3.3 Alendronate Price by Manufacturers
3.4 Alendronate Manufacturing Base Distribution, Product Types
3.4.1 Alendronate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alendronate Product Type
3.4.3 Date of International Manufacturers Enter into Alendronate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Alendronate Sales by Product
4.2 Global Alendronate Revenue by Product
4.3 Alendronate Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Alendronate Breakdown Data by End User
6 North America
6.1 North America Alendronate by Countries
6.1.1 North America Alendronate Sales by Countries
6.1.2 North America Alendronate Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Alendronate by Product
6.3 North America Alendronate by End User
7 Europe
7.1 Europe Alendronate by Countries
7.1.1 Europe Alendronate Sales by Countries
7.1.2 Europe Alendronate Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alendronate by Product
7.3 Europe Alendronate by End User
8 Asia Pacific
8.1 Asia Pacific Alendronate by Countries
8.1.1 Asia Pacific Alendronate Sales by Countries
8.1.2 Asia Pacific Alendronate Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Alendronate by Product
8.3 Asia Pacific Alendronate by End User
9 Central & South America
9.1 Central & South America Alendronate by Countries
9.1.1 Central & South America Alendronate Sales by Countries
9.1.2 Central & South America Alendronate Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Alendronate by Product
9.3 Central & South America Alendronate by End User
10 Middle East and Africa
10.1 Middle East and Africa Alendronate by Countries
10.1.1 Middle East and Africa Alendronate Sales by Countries
10.1.2 Middle East and Africa Alendronate Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Alendronate by Product
10.3 Middle East and Africa Alendronate by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Merck Alendronate Products Offered
11.1.5 Merck Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Business Overview
11.2.3 Teva Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Teva Alendronate Products Offered
11.2.5 Teva Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Company Business Overview
11.3.3 Mylan Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Mylan Alendronate Products Offered
11.3.5 Mylan Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Company Business Overview
11.4.3 Apotex Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Apotex Alendronate Products Offered
11.4.5 Apotex Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Pfizer Alendronate Products Offered
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Business Overview
11.6.3 Novartis Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Novartis Alendronate Products Offered
11.6.5 Novartis Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Company Business Overview
11.7.3 Eli Lilly Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Eli Lilly Alendronate Products Offered
11.7.5 Eli Lilly Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Company Business Overview
11.8.3 Amgen Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Amgen Alendronate Products Offered
11.8.5 Amgen Recent Development
11.9 Tecoland
11.9.1 Tecoland Company Details
11.9.2 Company Business Overview
11.9.3 Tecoland Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Tecoland Alendronate Products Offered
11.9.5 Tecoland Recent Development
11.10 Taj Pharmaceuticals
11.10.1 Taj Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Taj Pharmaceuticals Alendronate Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Taj Pharmaceuticals Alendronate Products Offered
11.10.5 Taj Pharmaceuticals Recent Development
12 Future Forecast
12.1 Alendronate Market Forecast by Regions
12.1.1 Global Alendronate Sales Forecast by Regions 2021-2027
12.1.2 Global Alendronate Revenue Forecast by Regions 2021-2027
12.2 Alendronate Market Forecast by Product
12.2.1 Global Alendronate Sales Forecast by Product 2021-2027
12.2.2 Global Alendronate Revenue Forecast by Product 2021-2027
12.3 Alendronate Market Forecast by End User
12.4 North America Alendronate Forecast
12.5 Europe Alendronate Forecast
12.6 Asia Pacific Alendronate Forecast
12.7 Central & South America Alendronate Forecast
12.8 Middle East and Africa Alendronate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alendronate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
